Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.

Cancer science - 1 Jun 2015

Zhang Guiming, Gu Chengyuan, Zhu Yao, Luo Lei, Dong Dahai, Wan Fangning, Zhang Hailiang, Shi Guohai, Sun Lijiang, Ye Dingwei

Abstract excerpt

Recent studies have indicated that low circulating adiponectin concentrations are associated with a higher risk of several cancers, including renal cell carcinoma. In this case-control study, we examined the frequency of single nucleotide polymorphisms (rs182052G>A, rs266729C>G, and rs3774262G>A) in the adiponectin gene (ADIPOQ) in 1004 patients with clear cell renal cell carcinoma (ccRCC) compared with a group...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiponectin
Share to Adolescent
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Renal Cell

Share to Case-Control Studies

Share to Kidney Neoplasms

Share to Logistic Models

Source

Open in PubMed Open full text

Identifiers

PMID: 25827778
DOI: 10.1111/cas.12664
PMCID: PMC4471788

Genes

ADIPOQ

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.PMID 25827778Read ↗

The association between adiponectin gene rs182052 polymorphism and cancer risk: a meta-analysis.Semantic proximity Read ↗

Genetic variation in the ADIPOQ gene and serum adiponectin increase the risk of bladder cancer.Semantic proximity Read ↗

Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.Semantic proximity Read ↗

Genetic variations of the ADIPOQgene and risk of prostate cancer in Chinese Han men.Semantic proximity Read ↗

Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese.Semantic proximity Read ↗

Exploring Adiponectin in Autosomal Dominant Kidney Disease: Insight and Implications.Semantic proximity Read ↗

The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies.Semantic proximity Read ↗

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.Semantic proximity Read ↗

Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trialSemantic proximity Read ↗

Fatty acid synthase (FASN), a novel signature for visceral adipose tissues, regulates proliferation, migration and predicts prognosis of clear cell renal cell carcinomaSemantic proximity Read ↗

Adiponectin (ADIPOQ) rs2241766 G/T polymorphism is associated with risk of cancer: evidence from a meta-analysis.Semantic proximity Read ↗

Association of leptin receptor Lys109Arg and Gln223Arg polymorphisms with increased risk of clear cell renal cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.